drugset / Trial / NCT01884038
Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant Recipients
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Patients undergoing orthotopic liver transplant will experience some degree of clinical and/or biochemical hepatic dysfunction. This early injury is known as primary graft dysfunction and varies from minor abnormalities to primary nonfunction. Prostaglandin-class drugs, including prostacyclin and its analogs, could represent an important advance toward the goal of reducing transplant related morbidity, mortality and associated costs by providing these benefits.
Timeline
- Start
- 2008-06
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Treprostinil | Other / unclassified | 5 unknown | Intravenous |
Indications
No indication recorded.